A real world, retrospective study to compare the outcomes of Abiraterone acetate treatment in patients with chemotherapy naive metastatic castration resistant prostate cancer with COU-AA-302 trial outcomes
Latest Information Update: 13 Feb 2024
Price :
$35 *
At a glance
- Drugs Abiraterone acetate (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 03 Apr 2017 New trial record
- 18 Feb 2017 Results presented at the 2017 Genitourinary Cancers Symposium